Literature DB >> 29425582

Identifying the best sleep measure to screen clinical insomnia in a psychiatric population.

Lee Seng Esmond Seow1, Edimansyah Abdin2, Sherilyn Chang2, Siow Ann Chong2, Mythily Subramaniam2.   

Abstract

BACKGROUND: Insomnia symptoms are highly prevalent among patients with psychiatric disorders, and this mandates the need to identify the best self-administered sleep measure to screen for clinical insomnia among them.
METHODS: A total of 400 psychiatric outpatients completed the Pittsburgh Sleep Quality Index, Insomnia Severity Index (ISI), Epworth Sleepiness Scale, Flinders Fatigue Scale, Functional Outcomes of Sleep Questionnaire, and Dysfunctional Beliefs and Attitudes about Sleep Scale in a cross-sectional study. The sensitivity, specificity, positive, and negative predictive values of these six sleep scales were assessed and compared in relation to both ICD-10 and DSM-5 insomnia disorder status established using the interviewer-administered Brief Insomnia Questionnaire.
RESULTS: Receiver operator characteristic curves with the area under the curve (AUC) revealed the ISI to be the most accurate measure to discriminate cases and non-cases on both ICD-10 (AUC = 0.88, 95% CI = 0.84-0.92) and DSM-5 (AUC = 0.82, 95% CI = 0.78-0.86) criteria with "good" accuracy. The cut-off scores of ≥14 and ≥ 11 for the ISI provided optimal sensitivity and specificity for the detection of ICD-10 and DSM-5 insomnia, respectively. DISCUSSION: With the new calling from DSM-5 to treat sleep symptoms in the presence of a co-existing mental condition, early detection of psychiatric patients with clinically significantly insomnia using a simple but accurate self-report sleep measure becomes important. Our study suggests that the ISI could be used as a potential screening tool for comorbid insomnia disorder in patients with mental disorders.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Insomnia disorder; Insomnia severity index; Psychiatric population

Mesh:

Year:  2017        PMID: 29425582     DOI: 10.1016/j.sleep.2017.09.015

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  9 in total

1.  Evaluating DSM-5 Insomnia Disorder and the Treatment of Sleep Problems in a Psychiatric Population.

Authors:  Lee Seng Esmond Seow; Swapna Kamal Verma; Yee Ming Mok; Sunita Kumar; Sherilyn Chang; Pratika Satghare; Aditi Hombali; Janhavi Vaingankar; Siow Ann Chong; Mythily Subramaniam
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

2.  A randomized controlled study of weighted chain blankets for insomnia in psychiatric disorders.

Authors:  Bodil Ekholm; Stefan Spulber; Mats Adler
Journal:  J Clin Sleep Med       Date:  2020-09-15       Impact factor: 4.062

3.  Validation of the Insomnia Severity Index (ISI) for identifying insomnia in young adult cancer survivors: comparison with a structured clinical diagnostic interview of the DSM-5 (SCID-5).

Authors:  Alexis L Michaud; Eric S Zhou; Grace Chang; Christopher J Recklitis
Journal:  Sleep Med       Date:  2021-02-04       Impact factor: 3.492

4.  ISI-3: evaluation of a brief screening tool for insomnia.

Authors:  Manu Thakral; Michael Von Korff; Susan M McCurry; Charles M Morin; Michael V Vitiello
Journal:  Sleep Med       Date:  2020-08-27       Impact factor: 4.842

5.  Tobacco cigarette smokers who endorse greater intolerance for nicotine withdrawal also report more severe insomnia symptoms.

Authors:  Emma C Lape; Lisa R LaRowe; Emily L Zale; Les A Gellis; Aesoon Park; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2021-02-25       Impact factor: 3.492

6.  Insomnia in Patients Seeking Care at an Orofacial Pain Unit.

Authors:  Miguel Meira E Cruz; Nenad Lukic; Aleksandra Wojczynska; Beat Steiger; Antonio Sérgio Guimarães; Dominik A Ettlin
Journal:  Front Neurol       Date:  2019-05-28       Impact factor: 4.003

7.  Effect of Cognitive Behavioral Therapy for Insomnia on Insomnia Symptoms for Individuals With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial.

Authors:  Mohammed M Alshehri; Aqeel M Alenazi; Jeffrey C Hoover; Shaima A Alothman; Milind A Phadnis; Christie A Befort; John M Miles; Jason L Rucker; Patricia M Kluding; Catherine F Siengsukon
Journal:  JMIR Res Protoc       Date:  2019-12-19

Review 8.  Allosteric Modulation of Adenosine A2A Receptors as a New Therapeutic Avenue.

Authors:  Mustafa Korkutata; Lokesh Agrawal; Michael Lazarus
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

9.  Sleep Quality and Insomnia Severity among Italian University Students: A Latent Profile Analysis.

Authors:  Matteo Carpi; Daniel Ruivo Marques; Alberto Milanese; Annarita Vestri
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.